Brief: Sino Biopharmaceutical Announces Disposal Of Equity Interest In Ct Tongyong
10/10/2023 11:34
Oct 10 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* DISPOSAL OF EQUITY INTEREST IN CT TONGYONG
* DISPOSAL OF EQUITY INTEREST AT A VALUATION OF RMB350
MILLION
* GROUP DISPOSED OF 84.2% EQUITY INTEREST IN SHANGHAI CHIA
TAI
TONGYONG PHARMACEUTICAL
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up